The NIH IMPROVE Act directs the National Institutes of Health to fund and conduct research aimed at reducing maternal mortality and addressing health disparities for pregnant and postpartum women.
Lauren Underwood
Representative
IL-14
The NIH IMPROVE Act directs the National Institutes of Health to continue and expand research aimed at reducing preventable maternal deaths and severe pregnancy-related complications. By prioritizing health equity and community-based interventions, the initiative seeks to address the biological and behavioral factors contributing to maternal health disparities across the United States. The bill authorizes $63.4 million in annual funding from 2026 through 2030 to support these critical research efforts.
The NIH IMPROVE Act is a direct response to a stark reality: the U.S. has one of the highest maternal mortality rates among developed nations. This bill officially amends the Public Health Service Act to cement the "Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone" (IMPROVE) Initiative within the National Institutes of Health. By authorizing $63.4 million annually from 2026 through 2030, the legislation aims to turn the tide on preventable deaths and severe complications that occur during pregnancy and the year following childbirth.
Under Section 409K, the NIH is tasked with investigating the biological, behavioral, and environmental factors that lead to life-threatening pregnancy outcomes. For a software engineer in a high-stress job or a construction worker in a rural area, this means the medical community is looking closer at how their specific lifestyles and locations impact their health. The bill specifically requires the NIH to build an "evidence base" for improving outcomes in specific U.S. regions, acknowledging that a mother’s zip code often dictates her quality of care. It’s not just about lab work; it’s about understanding why certain areas are seeing higher rates of complications and fixing the underlying issues.
A major pillar of this bill is its focus on health disparities. The legislation mandates the evaluation of community-based interventions for populations that are disproportionately affected by maternal mortality. For example, if data shows that Black or Indigenous women in a specific county are facing higher risks, the NIH can use grants and cooperative agreements to fund local programs tailored to those specific needs. By identifying the "biological mechanisms" behind leading causes of death, the initiative aims to move past guesswork and provide doctors with concrete protocols to save lives across all demographics.
To get these results, the bill gives the NIH Director the flexibility to use various funding tools, including grants and "other transaction methods," which can sometimes cut through the usual bureaucratic red tape to get projects moving faster. While $63.4 million a year is a significant investment in women’s health, the success of the IMPROVE Act will depend on how the NIH defines those broad "other factors" mentioned in the text. The goal is to ensure the money stays focused on the most critical maternal health risks rather than getting lost in generalized research. For families planning for the future, this bill represents a long-term commitment to making the journey from pregnancy to parenthood significantly safer.